Akero Therapeutics Stock Forward View - Relative Strength Index
| AKRODelisted Stock | USD 54.65 0.00 0.00% |
Akero Stock outlook is based on your current time horizon.
The value of RSI of Akero Therapeutics' share price is above 70 as of today. This suggests that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Akero, making its price go up or down. Momentum 73
Buy Stretched
Oversold | Overbought |
Using Akero Therapeutics hype-based prediction, you can estimate the value of Akero Therapeutics from the perspective of Akero Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Akero Therapeutics after-hype prediction price | USD 54.65 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Akero |
Akero Therapeutics Additional Predictive Modules
Most predictive techniques to examine Akero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akero using various technical indicators. When you analyze Akero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 73.54 | 73.54 |
| Check Akero Therapeutics Volatility | Backtest Akero Therapeutics | Information Ratio |
Akero Therapeutics Trading Date Momentum
| On February 02 2026 Akero Therapeutics was traded for 54.65 at the closing time. The top price for the day was 54.65 and the lowest listed price was 54.65 . There was no trading activity during the period 0.0. Lack of trading volume on February 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Akero Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akero Therapeutics stock to make a market-neutral strategy. Peer analysis of Akero Therapeutics could also be used in its relative valuation, which is a method of valuing Akero Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Akero Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Akero Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Akero Therapeutics shares will generate the highest return on investment. By undertsting and applying Akero Therapeutics stock market strength indicators, traders can identify Akero Therapeutics entry and exit signals to maximize returns.
Akero Therapeutics Risk Indicators
The analysis of Akero Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Akero Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting akero stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.1153 | |||
| Standard Deviation | 0.1473 | |||
| Variance | 0.0217 | |||
| Downside Variance | 0.0295 | |||
| Semi Variance | (0.03) | |||
| Expected Short fall | (0.14) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Akero Therapeutics
The number of cover stories for Akero Therapeutics depends on current market conditions and Akero Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Akero Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Akero Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Akero Therapeutics Short Properties
Akero Therapeutics' future price predictability will typically decrease when Akero Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Akero Therapeutics often depends not only on the future outlook of the potential Akero Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akero Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 67.1 M | |
| Cash And Short Term Investments | 743.1 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Akero Stock
If you are still planning to invest in Akero Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akero Therapeutics' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |